
Welcome to Pump.fun!
Pump lets anyone create coins, giving everyone equal access to buy and sell from the start. Prices can move quickly, so trade carefully.
By clicking this button, you agree to the Terms and Conditions, Privacy Policy, and certify that you are over 18 years old.
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
| No holders yet. | ||||||||||
**The Cancer Vaccine ($V940)** Intismeran (V940) is an investigational personalized mRNA cancer vaccine developed by Moderna and Merck. On August 19, 2026, the companies announced that V940 + KEYTRUDA met the primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival in a Phase 3 melanoma trial. The first positive Phase 3 readout for an individualized neoantigen therapy and an mRNA-based cancer therapy. $V940